Product Description
Overall, the global blood transfusion set market was valued at $480.1 million in 2023, a 3.5% decrease from $464.1 million in 2022. This is expected to increase over the forecast period at a CAGR of 3.0% to reach $591 million. Currently, the global blood transfusion market is dominated by Becton Dickinson (BD), Baxter, and ICU Medical.
Throughout this medical market research, we analyzed over 15 blood transfusion companies across 7 continents and used our comprehensive methodology to understand the market sizes, unit sales, company market shares, and to create accurate forecasts.
DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Value & Growth Trends
- Forecasts Until 2030, and Historical Data to 2020
- Market Drivers & Limiters for Each Segment
- Competitive Analysis with Market Shares for Each Segment
- Recent Mergers & Acquisitions
- COVID19 Impact
- Disease Overviews and Demographic Information
- Company Profiles, Product Portfolios and SWOT for Top Competitors
GLOBAL BLOOD TRANSFUSION MARKET INSIGHTS 
As chronic illnesses such as cancer, cardiovascular diseases, and blood disorders continue to rise in frequency, the necessity for regular blood transfusions as a critical component of treatment escalates. As the occurrence of these ailments increases, so does the requirement for blood transfusion kits, serving as a lifeline for individuals confronting these formidable health challenges. The escalating prevalence of chronic diseases emphasizes the pivotal function of blood transfusion kits in delivering vital care and assistance to those who require it, charting a course towards enhanced healthcare results.
GLOBAL BLOOD TRANSFUSION MARKET SHARE INSIGHTS
Becton Dickinson (BD) held the top position among competitors in the blood transfusion device market. BD provided a range of blood IV sets, available in both pump-based and gravity-based options, featuring a 180-µm filter, a pressure pump, a needleless connector, and male Luer lock adapters. These sets were specifically tailored for use with BD’s Alaris brand of infusion pumps. BD’s presence in the IV set market was significant, and in 2015, the company acquired its infusion therapy products from CareFusion, further solidifying its standing in the industry.
Baxter occupied the second-ranking position in the blood transfusion device market. The company offered a diverse array of blood collection and administration sets, encompassing standard blood in-line filters, Y-sites, male Luer lock injection adapters, and a pressure pump. Baxter held a prominent position in both the IV set and infusion pump markets, leveraging its strong foothold to drive sales of blood sets. Their product lineup included dual-chamber and single-chamber devices.
ICU Medical, the third-leading competitor in the blood transfusion device market, particularly excelled in North America. The company boasted an extensive range of products and disposables within its infusion therapy portfolio, which was further expanded through the acquisition of Smiths Medical. ICU Medical provided transfusion sets compatible with both gravity and infusion pumps. Additionally, they offered three distinct blood collection and administration tubing options, along with associated accessories, as part of their Saf-T Wing™ product line.
MARKET SEGMENTATION SUMMARY
- Blood Transfusion Market
Global Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.) Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam) Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2023 |
| Forecast | 2024-2030 |
| Historical Data | 2020-2023 |
| Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
